Edge Pharmaceuticals Limited
10581135
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 24/01/2017
DIRECTOR
BRITISH · UNITED KINGDOM · Age 67
Also on 71 other boards
Persons with Significant Control
Mr Geoffrey Hugh Melamet
British · United Kingdom · Age 67
Unit 13, 2nd Floor, Olympia House, Armitage Road, London, NW11 8RQ
Notified 24/01/2017
CompanyRankvs 99129+ SIC 96090 peers28
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2024
Turnover
£12k
Annual revenue
Net Worth
-£231k
Balance sheet strength
Cash
£47k
Cash in the bank
Profit Before Tax
£8k
Bottom line earnings
Net Current Assets
-£231k
Working capital
Current Assets
£214k
Current Liabilities
£445k
Debtors
£167k
Gross Profit
£12k
Admin Expenses
£4k
Operating Profit
£8k
Profit After Tax
£6k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.48 | +£6k |
| 2023 | 0.47 | -£17k |
| 2022 | 0.50 | -£663 |
| 2021 | 0.35 | +£8k |
| 2020 | 0.32 | -£242k |
| 2019 | 1.01 | — |
Derived from filed accounts. Not audited figures.